The global neprilysin market is anticipated to grow at a considerable CAGR during the forecast years. Neprilysin is a zinc-dependent metalloprotease used in the neprilysin inhibitors for the treatment of high blood pressure and heart failures. Acute heart failure is a chronic medical condition in which the heart doesn’t pump the blood as it is required. The reason for the growth of the market is there increasing the number of patients suffering from acute heart failure which is increasing the demand for the neprilysin for treatment. According to a report published on Wiley Online Library in June 2020, an estimated around 64.3 million people worldwide are living with acute heart failure. These numbers are expected to increase in the coming years. Due to the unhealthy lifestyle and eating habits of people, the number of acute heart failure patients is increasing across the globe. Thus, increasing the demand for neprilysin inhibitors for the treatment.
Get Free Sample link @ https://www.omrglobal.com/request-sample/neprilysin-market
In addition, there are several research and developments intended for the betterment of neprilysin inhibitors for the better treatment of acute heart failures and hypertension. According to a study published on ACP Internist in December 2021, the combination of angiotensin receptor and neprilysin inhibitors proved to be more beneficial in patients with acute heart failures. Furthermore, as per the report published by MDPI in August 2021, the report concludes that the combination of sacubitril and valsartan is the potent pharmacological agent to treat several cardiovascular diseases including acute heart failures. The several research and development coupled with the increasing number of acute heart failure patients, that is increasing the demand for neprilysin is expected to propel the growth of the global neprilysin market.
Full report of Neprilysin Market available @ https://www.omrglobal.com/industry-reports/neprilysin-market
Market Coverage
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Merck Group, GlaxoSmithKline plc, Cipla Ltd., Novartis International AG, Pharmaleads SA, and Others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Neprilysin Market Report Segment
By Type
- TD-0714
- Sacubitril
- PL-265
- STR-324
- LHW-090
By Application
- Acute Heart Failure
- Cancer Pain
- Hypertension
- Alzheimer’s Disease
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neprilysin-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
